We are live on ! Find out more
PCMI

Paradigm Capital Management Inc Portfolio holdings

AUM $2.61B
1-Year Est. Return 78.58%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+78.58%
3 Year Est. Return
+164.7%
5 Year Est. Return
+201.05%
10 Year Est. Return
+1,210.21%
AUM
$2.09B
AUM Growth
+$165M
Cap. Flow
+$1.79M
Cap. Flow %
0.09%
Top 10 Hldgs %
49.94%
Holding
137
New
6
Increased
24
Reduced
31
Closed
6

Top Buys

Rank Stock Value
1
ACLS icon
Axcelis
ACLS
+$31.9M
2
CRNC icon
Cerence
CRNC
+$18.9M
3
OFIX icon
Orthofix Medical
OFIX
+$14M
4
SIBN icon
SI-BONE Inc
SIBN
+$12.8M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$7.21M

Top Sells

Rank Stock Value
1
COHR icon
Coherent
COHR
+$37.9M
2
UCTT
Ultra Clean Holdings
UCTT
+$29M
3
MOD icon
Modine Manufacturing
MOD
+$25.5M
4
CTRN icon
Citi Trends
CTRN
+$5.44M
5
ENS icon
EnerSys
ENS
+$4.47M

Sector Composition

Rank Sector Weight
1 Technology 57.61%
2 Industrials 14.16%
3 Healthcare 13.38%
4 Consumer Discretionary 11.46%
5 Materials 2.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUMZ icon
126
Zumiez
ZUMZ
$339M
$293K 0.01%
+19,318
New +$330K
TMCI icon
127
Treace Medical Concepts
TMCI
$309M
$261K 0.01%
+20,000
New +$267K
BAX icon
128
Baxter International
BAX
$14.2B
$227K 0.01%
5,300
TBRG
129
DELISTED
TruBridge
TBRG
$184K 0.01%
+20,000
New +$193K
OOMA icon
130
Ooma
OOMA
$604M
$171K 0.01%
20,000
TBHC
131
DELISTED
The Brand House Collective
TBHC
$103K 0.01%
42,900
FOSL icon
132
Fossil Group
FOSL
$318M
-239,100
Closed -$349K
OGN icon
133
Organon & Co
OGN
$3.57B
-260,600
Closed -$3.76M
OMCL icon
134
Omnicell
OMCL
$1.68B
-52,000
Closed -$1.96M
TLYS icon
135
Tilly's
TLYS
$128M
-60,700
Closed -$458K
RVNC
136
DELISTED
Revance Therapeutics, Inc.
RVNC
-20,000
Closed -$176K
CAMP
137
DELISTED
CalAmp Corp.
CAMP
-2,174
Closed -$12.6K

Similar funds

Paradigm Capital Management Inc's Q1 2024 Portfolio in Review

As of Q1 2024, Paradigm Capital Management Inc held 137 positions worth $2.09B, up 8.6% from $1.92B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Paradigm Capital Management Inc's Q1 2024 filing shows 6 new, 24 increased, 31 reduced and 6 closed positions. Its largest new stake was AngioDynamics: 1,079,100 shares worth $6.33M. The largest sale was Coherent, an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 58% of assets, down from 60% a quarter earlier, followed by Industrials and Healthcare.

  • Paradigm Capital Management Inc's largest Q1 2024 buy was AngioDynamics: 1,079,100 shares worth $6.33M.
  • Paradigm Capital Management Inc added most to Axcelis in Q1 2024, an estimated $31.9M increase.
  • Paradigm Capital Management Inc's biggest Q1 2024 reduction was Coherent, cutting an estimated $37.9M.
  • Paradigm Capital Management Inc fully exited Organon & Co in Q1 2024, selling an estimated $3.76M.
  • Paradigm Capital Management Inc's ten largest holdings make up 50% of its $2.09B portfolio in Q1 2024.
  • Paradigm Capital Management Inc opened 6 new positions and closed 6 in Q1 2024.
  • Paradigm Capital Management Inc's portfolio value rose 8.6% quarter-over-quarter to $2.09B.

Based on Paradigm Capital Management Inc's 13F filing for Q1 2024, filed 15 May 2024.